Gardasil, the first anti-cancer vaccine was approved by the Therapeutic Goods Administration to be used on girls from the age of nine to 26 and boys aged from nine to 15.
The vaccine was developed by 2006 Australian of the Year, Professor Ian Frazer.
The vaccine is designed to prevent cervical cancer and the human papillomavirus (HPV) related to cancers and diseases.
Hayley, Gilkes of Oakeden was the first South Australian to get the vaccine. The 18-year-old said it was ""great that the vaccine is now available and I am excited to be the first in SA to receive it".
CSL, an Australian manufacturer has applied for funding from the government through the National Immunisation Program.
By 2008, it is planned to be part of a school-based program.
Dr Gerry Wain, the New South Wales cervical screening program's scientific director told Xinhuanet, "We've been managing very well at preventing cervical cancer with cervical screening up till now with pap tests but this gives us an additional method of preventing this terrible disease."
The standard three-dose course costs $459, which comes out to $153 per dose.
